Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
1
14%
Ph phase_3
6
86%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
6(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Terminated(1)

Detailed Status

Completed6
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (14.3%)
Phase 36 (85.7%)

Trials by Status

completed686%
terminated114%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation

NCT01213368
completedphase_3

Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

NCT00489736
terminatedphase_3

European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

NCT00696631
completedphase_3

American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

NCT00259376
completedphase_3

EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)

NCT00259428
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01213368Phase 2

Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation

Completed
NCT00489736Phase 3

Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Completed
NCT00696631Phase 3

European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

Terminated
NCT00259376Phase 3

American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm

Completed
NCT00259428Phase 3

EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)

Completed
NCT00174785Phase 3

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

Completed
NCT00697086Phase 3

European Study of Dronedarone in Atrial Fibrillation

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7